Get the Stockscreener App
2.00
3.63%
0.07
Pre-market:
1.98
-0.02
-1.00%
Acumen Pharmaceuticals Inc Stock (ABOS) Forecast
The Acumen Pharmaceuticals Inc (ABOS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.895, representing a -55.25% decrease from the current price of $2.00. The highest analyst price target is $0.67, and the lowest is $1.12.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ABOS Price Target
Average 3.0692
(+53.46% Upside)
Is Acumen Pharmaceuticals Inc (ABOS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 55.92 | Neutral |
| STOCH(9,6) | 75.36 | Neutral |
| STOCHRSI(14) | 100.00 | Sell |
| MACD(12,26) | -0.00489 | Buy |
| ADX(14) | 19.14 | Neutral |
| William %R | -5.6604 | Sell |
| CCI(14) | 68.91 | Neutral |
Buy: 1
Sell: 2
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.818
Buy
|
1.8599
Buy
|
| MA20 |
1.805
Buy
|
1.8554
Buy
|
| MA50 |
1.9224
Buy
|
1.8218
Buy
|
| MA100 |
1.6597
Buy
|
1.701
Buy
|
| MA200 |
1.4004
Buy
|
1.7096
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, ABOS could be considered a Strong Buy, with 17 technical analysis indicators signaling 11 Buy signals, 2 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on ABOS, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 55.92 indicates that ABOS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 75.36 indicates that ABOS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100 indicates that ABOS is oversold. This suggests that ABOS price is at or near the highest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 19.14 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 68.91 indicates that ABOS is still overbought but not to an extreme extent.
Long-term ABOS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acumen Pharmaceuticals Inc financial reports and earnings history, Acumen Pharmaceuticals Inc (ABOS) stock could reach $6.3484 by 2030, $56.07 by 2040 and $88.15 by 2050. See the projected annual prices until 2050 of the Acumen Pharmaceuticals Inc stock below:
- Acumen Pharmaceuticals Inc (ABOS) is expected to reach an average price of $22.12 in 2035, with a high prediction of $27.01 and a low estimate of $27.08. This indicates an $1,006% rise from the last recorded price of $2.00.
- Acumen Pharmaceuticals Inc (ABOS) stock is projected to chart a bullish course in 2040, with an average price target of $56.35, representing an $2,718% surge from its current level. The forecast ranges from a conservative $9.9092 to a sky-high $56.07.
- Our analysts predict Acumen Pharmaceuticals Inc (ABOS) to jump 1,937% by 2045, soaring from $40.83 to an average price of $40.74, potentially reaching $40.52. While $40.83 is the low estimate, the potential upside is significant.
- Acumen Pharmaceuticals Inc (ABOS) stock is expected to climb by 2050, reaching an average of $86.47, a $4,223% jump from its current level. However, a wide range of estimates exists, with high and low targets of $88.15 and $87.04, respectively, highlighting the market's uncertainty.
Acumen Pharmaceuticals Inc Stock (ABOS) Year by Year Forecast
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2026
The predicted value for Acumen Pharmaceuticals Inc (ABOS) in 2026 is set at an average of $3.0692. Estimates vary from a peak of $5.9577 to a trough of $0.1806, indicating an +53.46% surge from the present price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1.08 | $1.12 | $0.67 | -46.00% |
| February, 2026 | $1.3215 | $1.3629 | $1.2115 | -33.92% |
| March, 2026 | $2.2631 | $1.9844 | $2.1202 | +13.15% |
| April, 2026 | $0.7475 | $2.4575 | $2.0596 | -62.62% |
| May, 2026 | $0.8791 | $0.7733 | $0.7091 | -56.05% |
| June, 2026 | $0.1606 | $0.1806 | $0.8423 | -91.97% |
| July, 2026 | $2.0349 | $0.5293 | $5.9577 | +1.75% |
| August, 2026 | $1.2234 | $1.1421 | $2.4391 | -38.83% |
| September, 2026 | $0.7489 | $0.4889 | $1.7705 | -62.55% |
| October, 2026 | $0.8126 | $0.304 | $0.731 | -59.37% |
| November, 2026 | $2.1342 | $1.1036 | $2.0242 | +6.71% |
| December, 2026 | $1.3886 | $1.6686 | $2.0171 | -30.57% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acumen Pharmaceuticals Inc (ABOS) is $7.5436, with a high forecast of $15.07 and a low forecast of $0.0169. This indicates an +277.18% increase from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.0298 | $0.2552 | $1.0215 | -98.51% |
| February, 2027 | $0.3417 | $0.0169 | $0.864 | -82.91% |
| March, 2027 | $0.2638 | $0.0562 | $0.2638 | -86.81% |
| April, 2027 | $1.1123 | $0.3209 | $1.9652 | -44.39% |
| May, 2027 | $0.9007 | $0.3565 | $1.4365 | -54.96% |
| June, 2027 | $8.67 | $0.3178 | $8.39 | +333.50% |
| July, 2027 | $7.7931 | $5.9973 | $6.2508 | +289.66% |
| August, 2027 | $8.0962 | $7.4389 | $6.6362 | +304.81% |
| September, 2027 | $8.3351 | $8.5151 | $8.0535 | +316.76% |
| October, 2027 | $13.63 | $9.1409 | $11.38 | +581.41% |
| November, 2027 | $14.56 | $14.13 | $14.19 | +628.07% |
| December, 2027 | $15.69 | $14.72 | $15.07 | +684.51% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2028
In 2028, Acumen Pharmaceuticals Inc (ABOS) is projected to reach an average price of $11.18, with a high projection of $15.51 and a low estimate of $6.8486. This indicates an +458.87% rise from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $15.02 | $15.59 | $15.51 | +651.17% |
| February, 2028 | $14.94 | $14.38 | $14.26 | +646.82% |
| March, 2028 | $15.38 | $14.50 | $15.30 | +668.77% |
| April, 2028 | $15.07 | $15.22 | $15.15 | +653.42% |
| May, 2028 | $14.82 | $14.90 | $14.89 | +640.87% |
| June, 2028 | $14.15 | $14.59 | $14.43 | +607.52% |
| July, 2028 | $11.15 | $11.84 | $12.76 | +457.68% |
| August, 2028 | $12.09 | $11.65 | $11.52 | +504.62% |
| September, 2028 | $9.6755 | $10.67 | $10.94 | +383.78% |
| October, 2028 | $6.1386 | $6.8486 | $10.83 | +206.93% |
| November, 2028 | $9.0275 | $8.0244 | $8.1475 | +351.38% |
| December, 2028 | $9.2506 | $9.1133 | $8.5648 | +362.53% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2029
The 2029 price forecast for Acumen Pharmaceuticals Inc Stock (ABOS) is $6.0442 on average, with a high prediction of $8.8925 and a low estimate of $3.1959. This represents an +202.21% increase from the previous price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $8.9595 | $9.2464 | $8.8925 | +347.98% |
| February, 2029 | $8.4526 | $8.5768 | $8.4453 | +322.63% |
| March, 2029 | $7.9357 | $7.8999 | $7.4764 | +296.79% |
| April, 2029 | $8.4288 | $8.0373 | $7.763 | +321.44% |
| May, 2029 | $8.6777 | $8.7177 | $8.5004 | +333.89% |
| June, 2029 | $6.3608 | $7.5708 | $8.1543 | +218.04% |
| July, 2029 | $6.3339 | $6.6938 | $6.5182 | +216.70% |
| August, 2029 | $5.8728 | $5.7613 | $6.0297 | +193.64% |
| September, 2029 | $3.0759 | $3.1959 | $3.8686 | +53.80% |
| October, 2029 | $3.8848 | $3.4317 | $3.5348 | +94.24% |
| November, 2029 | $4.9979 | $3.8206 | $3.9929 | +149.90% |
| December, 2029 | $5.531 | $5.1895 | $5.091 | +176.55% |
Acumen Pharmaceuticals Inc Stock (ABOS) Price Forecast for 2030
Acumen Pharmaceuticals Inc Stock (ABOS) is expected to reach an average price of $12.79 in 2030, with a high forecast of $23.57 and a low forecast of $1.9997. This signifies an +539.27% surge from the last price of $2.00.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.1399 | $6.4699 | $6.3484 | +207.00% |
| February, 2030 | $5.193 | $5.383 | $5.8807 | +159.65% |
| March, 2030 | $3.4861 | $3.7361 | $4.7738 | +74.31% |
| April, 2030 | $3.8692 | $3.5619 | $3.6192 | +93.46% |
| May, 2030 | $2.1681 | $2.9181 | $3.705 | +8.41% |
| June, 2030 | $1.7212 | $1.9997 | $1.6455 | -13.94% |
| July, 2030 | $2.2801 | $2.0628 | $2.1311 | +14.01% |
| August, 2030 | $18.31 | $2.0767 | $20.31 | +815.43% |
| September, 2030 | $17.90 | $17.75 | $17.04 | +795.17% |
| October, 2030 | $20.54 | $19.83 | $18.80 | +926.83% |
| November, 2030 | $18.48 | $19.69 | $19.35 | +824.07% |
| December, 2030 | $24.78 | $20.37 | $23.57 | +1,139% |
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):